IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,368 | -36.5% | 3,597,120 | -1.8% | 0.00% | -50.0% |
| Q2 2023 | $25,791 | +12.4% | 3,663,373 | -2.5% | 0.00% | +33.3% |
| Q1 2023 | $22,949 | -6.7% | 3,755,868 | -2.4% | 0.00% | -25.0% |
| Q4 2022 | $24,593 | -99.9% | 3,848,731 | -18.3% | 0.00% | -42.9% |
| Q3 2022 | $45,135,000 | -6.0% | 4,711,314 | +8.3% | 0.01% | +16.7% |
| Q2 2022 | $48,032,000 | -44.1% | 4,350,685 | -15.6% | 0.01% | -33.3% |
| Q1 2022 | $85,858,000 | -3.6% | 5,156,646 | +10.6% | 0.01% | +12.5% |
| Q4 2021 | $89,032,000 | -21.9% | 4,663,785 | +0.8% | 0.01% | -27.3% |
| Q3 2021 | $114,046,000 | -5.8% | 4,624,728 | -0.6% | 0.01% | 0.0% |
| Q2 2021 | $121,007,000 | -25.6% | 4,650,552 | -9.4% | 0.01% | -31.2% |
| Q1 2021 | $162,589,000 | -52.5% | 5,135,456 | -30.4% | 0.02% | -54.3% |
| Q4 2020 | $342,534,000 | +50.2% | 7,382,205 | +6.5% | 0.04% | +34.6% |
| Q3 2020 | $228,110,000 | +14.3% | 6,929,214 | -4.7% | 0.03% | +4.0% |
| Q2 2020 | $199,628,000 | -1.6% | 7,272,430 | +7.3% | 0.02% | -21.9% |
| Q1 2020 | $202,972,000 | +12.6% | 6,780,431 | +4.2% | 0.03% | +39.1% |
| Q4 2019 | $180,193,000 | +52.2% | 6,509,856 | +0.1% | 0.02% | +35.3% |
| Q3 2019 | $118,393,000 | -19.8% | 6,505,083 | +8.0% | 0.02% | -19.0% |
| Q2 2019 | $147,706,000 | +344.7% | 6,023,903 | +72.5% | 0.02% | +320.0% |
| Q1 2019 | $33,216,000 | +13.6% | 3,492,734 | +5.7% | 0.01% | 0.0% |
| Q4 2018 | $29,249,000 | -16.7% | 3,305,027 | +5.8% | 0.01% | 0.0% |
| Q3 2018 | $35,128,000 | -16.6% | 3,122,499 | -5.2% | 0.01% | -16.7% |
| Q2 2018 | $42,141,000 | +42.8% | 3,292,287 | +88.5% | 0.01% | +20.0% |
| Q1 2018 | $29,510,000 | – | 1,746,144 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |